Cashu
Natera's Q4 Earnings Show Strong Growth and Commitment to Innovative Genetic Testing Solutions
4 days ago
Stocks
Health Care
ntra
Natera
NASDAQ: NTRA
-2.41 (-1.16%)
204.63
USD
At close at Mar 04, 18:08 UTC
Overview
Loading chart...
Key Stats
Market Cap
28.57B
Dividend Yield
0.00%
P/E Ratio
-137.27
EPS
-1.53
Revenue
1.70B
Avg. Volume
1.60M
About
What does NTRA do?
Natera is a Texas-based diagnostics company specializing in genetic testing services and employs 3,282 people. Its offerings include non-invasive prenatal testing and a cloud-based software platform for lab customers.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.